Mahana Therapeutics Signs Agreement with Consumer Health Division of Bayer to Commercialize Digital Therapeutics
Mahana Therapeutics, a leading provider of prescription digital therapeutics, announced today that the company has entered into a multi-million-dollar distribution and marketing partnership with the Consumer Health division of Bayer to commercialize digital therapeutics. Earlier this year, Bayer announced the launch of a new business unit focused on delivering new digitally enabled precision health products to market. 
Health technology trade association ABHI has announced that specialist marketing, PR and communications agency Highland Marketing has joined its membership.
Frimley Health NHS Foundation Trust and Qure.ai have announced the early results of a pilot study using an innovative radiology AI solution to read and differentiate between normal and abnormal chest X-rays (CXRs).
NHS Fife is working with Buddy Healthcare on a digital pre-op pathway, so orthopaedic patients can complete assessments on an app and clinicians can use the data to make the best possible use of outpatient clinic and theatre time.
A new microperspective in the ACS journal Medicinal Chemistry Letters evaluates recent research on artificial intelligence (AI)-generated molecular structures from the point of view of the medicinal chemist and recommends guidelines for assessing the novelty and validity of these compounds. 
NHS technology provider C2-Ai has been recognised at four high-profile UK healthcare and technology awards on a single night, after surgical teams across dozens of hospitals delivered significant impact for patients on waiting lists.